business
BlackRock Discloses 4.4% Aura Biosciences Stake
Archived — last updated
BlackRock has disclosed a 4.4% stake in Aura Biosciences, with the investment firm reporting beneficial ownership of 4,582,436 shares of common stock.
Latest updates
BlackRock Discloses 4.4% Aura Biosciences Stake
BlackRock has disclosed a 4.4% stake in Aura Biosciences, with the investment firm reporting beneficial ownership of 4,582,436 shares of common stock. The stake is valued at over $200 million, making BlackRock one of the largest shareholders in the company. Aura Biosciences is a biotechnology company that is developing treatments for cancer and other diseases.
Sources
AI-assisted summary of the reporting above. Quotes are kept to one sentence. Copyright concern? See our DMCA takedown page.
Related stories
EU considers acting on Russia shadow fleet sanctions without US support
Since Russia's full-scale invasion of Ukraine , Moscow has increasingly relied on a so-called shadow fleet to bypass Western sanctions and
France plans €4bn education spending amid debt concerns and nationwide protests
France plans €4bn for schools and €1bn for universities despite 120% debt and nationwide protests.
India raises fiscal year growth forecast to 7.3% amid Middle East instability
India's Ministry of Finance expects India's economy to grow at a pace of 7.3% in the current fiscal year based on its latest assessment of